Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1853 1
1856 2
1858 2
1864 1
1871 2
1873 1
1874 1
1882 1
1883 5
1886 1
1887 1
1888 1
1892 1
1899 1
1910 1
1920 2
1921 1
1929 1
1930 1
1931 1
1932 2
1933 4
1935 5
1936 2
1937 5
1939 2
1940 2
1941 1
1942 1
1946 12
1947 9
1948 11
1949 8
1950 14
1951 15
1952 8
1953 18
1954 7
1955 15
1956 15
1957 18
1958 9
1959 13
1960 19
1961 13
1962 13
1963 13
1964 19
1965 24
1966 20
1967 16
1968 15
1969 21
1970 15
1971 24
1972 21
1973 23
1974 31
1975 30
1976 31
1977 31
1978 39
1979 57
1980 55
1981 52
1982 69
1983 63
1984 54
1985 70
1986 72
1987 58
1988 68
1989 92
1990 98
1991 90
1992 94
1993 78
1994 84
1995 77
1996 64
1997 84
1998 118
1999 94
2000 98
2001 98
2002 82
2003 107
2004 138
2005 128
2006 138
2007 132
2008 177
2009 168
2010 161
2011 162
2012 190
2013 164
2014 157
2015 164
2016 169
2017 168
2018 190
2019 177
2020 176
2021 204
2022 187
2023 190
2024 177
2025 166
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,880 results

Results by year

Filters applied: . Clear all
Page 1
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, Zhou C, Reungwetwattana T, Cheng Y, Chewaskulyong B, Shah R, Cobo M, Lee KH, Cheema P, Tiseo M, John T, Lin MC, Imamura F, Kurata T, Todd A, Hodge R, Saggese M, Rukazenkov Y, Soria JC; FLAURA Investigators. Ramalingam SS, et al. Among authors: gray je. N Engl J Med. 2020 Jan 2;382(1):41-50. doi: 10.1056/NEJMoa1913662. Epub 2019 Nov 21. N Engl J Med. 2020. PMID: 31751012 Free article. Clinical Trial.
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
Rozenblatt-Rosen O, Regev A, Oberdoerffer P, Nawy T, Hupalowska A, Rood JE, Ashenberg O, Cerami E, Coffey RJ, Demir E, Ding L, Esplin ED, Ford JM, Goecks J, Ghosh S, Gray JW, Guinney J, Hanlon SE, Hughes SK, Hwang ES, Iacobuzio-Donahue CA, Jané-Valbuena J, Johnson BE, Lau KS, Lively T, Mazzilli SA, Pe'er D, Santagata S, Shalek AK, Schapiro D, Snyder MP, Sorger PK, Spira AE, Srivastava S, Tan K, West RB, Williams EH; Human Tumor Atlas Network. Rozenblatt-Rosen O, et al. Among authors: gray jw. Cell. 2020 Apr 16;181(2):236-249. doi: 10.1016/j.cell.2020.03.053. Cell. 2020. PMID: 32302568 Free PMC article. Review.
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
Moreno L, Weston R, Owens C, Valteau-Couanet D, Gambart M, Castel V, Zwaan CM, Nysom K, Gerber N, Castellano A, Laureys G, Ladenstein R, Rössler J, Makin G, Murphy D, Morland B, Vaidya S, Thebaud E, van Eijkelenburg N, Tweddle DA, Barone G, Tandonnet J, Corradini N, Chastagner P, Paillard C, Bautista FJ, Gallego Melcon S, De Wilde B, Marshall L, Gray J, Burchill SA, Schleiermacher G, Chesler L, Peet A, Leach MO, McHugh K, Hayes R, Jerome N, Caron H, Laidler J, Fenwick N, Holt G, Moroz V, Kearns P, Gates S, Pearson ADJ, Wheatley K; Innovative Therapies for Children with Cancer (ITCC) and European Association for Neuroblastoma Research (SIOPEN). Moreno L, et al. Among authors: gray j. J Clin Oncol. 2024 Apr 1;42(10):1135-1145. doi: 10.1200/JCO.23.00458. Epub 2024 Jan 8. J Clin Oncol. 2024. PMID: 38190578 Free PMC article. Clinical Trial.
Eccrine nevus.
Kawaoka JC, Gray J, Schappell D, Robinson-Bostom L. Kawaoka JC, et al. Among authors: gray j. J Am Acad Dermatol. 2004 Aug;51(2):301-4. doi: 10.1016/j.jaad.2003.12.030. J Am Acad Dermatol. 2004. PMID: 15280853
Cytometry and genetics.
Cram LS, Gray JW, Carter NP. Cram LS, et al. Among authors: gray jw. Cytometry A. 2004 Mar;58(1):33-6. doi: 10.1002/cyto.a.20008. Cytometry A. 2004. PMID: 14994217 Free article. Review. No abstract available.
Chromosome aberrations in solid tumors.
Albertson DG, Collins C, McCormick F, Gray JW. Albertson DG, et al. Among authors: gray jw. Nat Genet. 2003 Aug;34(4):369-76. doi: 10.1038/ng1215. Nat Genet. 2003. PMID: 12923544 Review.
The zoonotic potential of rotavirus.
Cook N, Bridger J, Kendall K, Gomara MI, El-Attar L, Gray J. Cook N, et al. Among authors: gray j. J Infect. 2004 May;48(4):289-302. doi: 10.1016/j.jinf.2004.01.018. J Infect. 2004. PMID: 15066329 Review.
Rotavirus epidemiology and surveillance.
Desselberger U, Iturriza-Gómara M, Gray JJ. Desselberger U, et al. Among authors: gray jj. Novartis Found Symp. 2001;238:125-47; discussion 147-52. doi: 10.1002/0470846534.ch9. Novartis Found Symp. 2001. PMID: 11444024 Review.
Too many 'superbugs'.
Gray J. Gray J. Nurs Stand. 2003 Jan 15-21;17(18):3. Nurs Stand. 2003. PMID: 12599973 No abstract available.
Winning back control.
Gray J. Gray J. Nurs Stand. 2004 Jul 14-20;18(44):3. Nurs Stand. 2004. PMID: 15317246 No abstract available.
5,880 results